Take the Test: Evaluating Commercial Readiness, Pt I
By Mark Warner, PE, Founder, Warner Advisors LLC Special to The Digest In my previous series What makes the scale-up of industrial biotechnology so difficult?, I discussed the need for a fully integrated pilot plant and reviewed common pitfalls that companies face on their path to commercialization. The series generated the obvious question as to how […]











